Posted 17 May 2013 - 09:29 AM
and now it's Mediclinic's turn
MEDICLINIC INTERNATIONAL LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
(Share code: MDC)
(ISIN: ZAE000074142)
("Mediclinic" or “the Company”)
TRADING STATEMENT – AUDITED GROUP RESULTS FOR THE YEAR ENDED
31 MARCH 2013
In terms of the JSE Limited (“JSE”) Listings Requirements,
companies are required to publish a trading statement as soon as
they are satisfied that a reasonable degree of certainty exists
that the financial results for the period to be reported upon next
will differ by at least 20% from that of the previous
corresponding reporting period. Mediclinic is in the process of
finalising its year-end results for the twelve months ended 31
March 2013, which are due to be released on SENS on 22 May 2013
and published in the press on 23 May 2013 (“year-end results
announcement”).
Accordingly, shareholders are advised that the Company’s basic
earnings per share (“EPS”) and basic headline earnings per share
(“HEPS”) for the year ended 31 March 2013 are expected to be
between 164% and 174% lower than that reported for the previous
corresponding reporting period (“the EPS and HEPS range”).
Do not try and bend the market. That's impossible. Instead... only try to realize the truth. Then you'll see, that it is not the market that bends, it is only yourself.